SSB launches small-scale disposable reactor

- Last updated on GMT

Related tags: Biotechnology, Chemical engineering

Sartorius Stedim Biotech (SSB) has launched a new small-scale bioreactor citing growing biopharmaceutical company demand for scale-up technologies as the key driver for its development.

The new platform, named the UniVessel SU, is a single-use, stirred tank reactor that has a two litre working volume which, according to SSB, makes it ideal for process development.

Andre Grebe​, company head of product management multi-use bioreactors, told in-Pharmatechnologist.com that “Demand is very healthy, mainly for process development in the biopharmaceutical space​.”

He explained that fully-disposable systems like UniVessel meet industry demands for technologies that allow the maximum number of experiments to be conducted at the lowest operational and maintenance cost.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us